David Fuller
Last Updated On: October 3, 2024
Osteoarthritis is a common degenerative joint disease that affects millions worldwide. It causes significant pain and reduced mobility. According to the Centers for Disease Control and Prevention (CDC), about 33 million adults in the U.S. suffer from osteoarthritis.
Synvisc One, a viscosupplementation treatment, aims to alleviate the pain and stiffness associated with osteoarthritis by injecting hyaluronan directly into the knee joint. This single-injection treatment mimics the natural synovial fluid in joints, providing lubrication and cushioning to ease movement and reduce discomfort.
In this article, we will explore Synvisc One’s pros and cons, delving into its effectiveness, potential side effects, and patient experiences to help you make an informed decision.
About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. If you’re looking to buy Synvisc online, contact our sales department for more information.
Synvisc One is an injectable treatment designed to alleviate knee pain caused by osteoarthritis. The active ingredient is hylan G-F 20, a gel-like substance that mimics the natural synovial fluid in the knee. By enhancing lubrication and cushioning within the joint, Synvisc One improves mobility and reduces pain.
Approved by the US Food and Drug Administration (FDA) in 2009, Synvisc One has a strong safety profile backed by extensive clinical research. It is administered as a single injection, providing long-lasting relief, typically up to six months. The treatment’s convenience and efficacy make it a popular choice for managing knee osteoarthritis symptoms.
While this treatment brings many benefits, it’s also key to note the downsides, like possible Synvisc side effects and the fact that not everyone may get the same relief from pain.
Evaluating Synvisc One’s efficacy and safety involves analyzing clinical trial data. This method gives medical professionals a clear basis for understanding Synvisc One’s effectiveness and safety. The following table summarizes key findings from various clinical trials, focusing on pain relief, joint mobility, and side effect occurrence outcomes.
Clinical Trial | Key Findings | Efficacy Results | Safety Observations |
Multicenter Randomized Study | Compared single injection Synvisc One with placebo | Significantly reduced pain scores at 26 weeks | Minor side effects, similar to placebo |
Extended Evaluation Study | Long-term efficacy and safety over 1 year | Pain relief sustained over 52 weeks | Low incidence of serious adverse events |
Comparative Effectiveness Trial | Assessed against other hyaluronic acid injections | Comparable or better improvement in joint function | Similar safety profile to other HA products |
Patients often share their experiences with Synvisc One, highlighting both the upsides and challenges. These stories can offer a unique perspective on the treatment’s effects.
Choosing Synvisc One involves careful thought. Talk with a doctor and think about what you need and want.
Synvisc One provides long-lasting pain relief and improved joint function with a single injection. However, potential side effects and cost may be concerns, and results can vary. Consulting a healthcare professional can help determine if Synvisc One aligns with your needs and preferences.
Synvisc One is a medical treatment for managing knee osteoarthritis pain.
Synvisc One provides long-term pain relief, improves mobility, and enhances overall quality of life.
Potential drawbacks include side effects such as swelling or fluid build-up around the knee.
It’s essential to discuss the pros and cons with your healthcare provider to make an informed decision.
Centers for Disease Control and Prevention Osteoarthritis. Published January 26, 2024. https://www.cdc.gov/arthritis/osteoarthritis/index.html
In Y, Ha CW. A Multicenter, Randomized, Double-Blinded, Parallel-Group, Placebo-Controlled Phase I/IIa Study to Evaluate the Efficacy and Safety of a Single Intra-Articular Injection of YYD302 in Patients with Knee Osteoarthritis. Journal of Clinical Medicine. 2022;11(6):1482. doi:https://doi.org/10.3390/jcm11061482
Products
Cart
Log In
Newsletter
Subscribe for exclusive offers and updates on new arrivals
Share feedback at:
Working Hours
MON - SUN 9AM to 6PM EST
The Most Popular Brands
Med Supply Solutions
Support
Secure checkout is guaranteed with full adherence to PCI DSS payment standards.
Products listed here are guaranteed authentic and manufacturer-sourced.
Pay easily with trusted providers
*Google and Apple Pay are currently only available via a direct link provided by your account manager.
Copyright 2025. Med Supply Solutions